Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT05588674 |
Other study ID # |
LEON7551 |
Secondary ID |
|
Status |
Recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
October 1, 2022 |
Est. completion date |
July 31, 2024 |
Study information
Verified date |
December 2023 |
Source |
Loughborough University |
Contact |
Liam M Heaney, PhD |
Phone |
01509226424 |
Email |
L.M.Heaney2[@]Lboro.ac.uk |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This project will involve administering a multi-strain probiotic supplement to investigate
the capacity to improve exercise performance and/or recovery. This will be done by assessing
physiological measures (e.g. performance and muscle soreness), biochemical measures (e.g.
oxidative stress and inflammation), and microbial diversity (i.e. associations with bacteria
present in the gut). Participants will be well-trained, recreational exercisers and will
visit the laboratory a total of eight times, including an 8-week probiotic vs placebo
supplementation period.
Description:
A total of 36 healthy, and active men and women aged 18-40 years of age will be recruited and
allocated randomly into either a probiotic or placebo group, where both the investigator and
participants will be blinded to the supplements (double-blind randomised control trial
format).
Each participant will be asked to attend the research laboratory on eight separate occasions
and to refrain from high-intensity exercise (e.g. long-distance running, competitive sport,
weightlifting) in the 48 hours prior to each visit and light exercise (e.g. mild jogging or
long walk) the day before each visit. They will also be asked to refrain from alcohol intake
for 24 hours before each visit and caffeine intake on the morning of the visit.
Visit 1
Following consent, the participants will complete a ramp incremental exercise test for
determination of volume of peak oxygen uptake (VO2peak) and the first abrupt change in the
oxygen (VO2) and carbon dioxide (VCO2) concentrations of the expired air known as Gas
Exchange Threshold (GET). The data collected during the incremental test will be used to
calculate the work rates which will be employed during the subsequent exercise tests. The
participant will also be asked to complete a food frequency and exercise questionnaire to
understand general dietary and training practices.
Visit2
At least 48 hours following visit 1, the participant will return to the exercise laboratory
in the morning after a 10-hour overnight fast, where they will complete a familiarisation to
the cycling time trial performance test. The time trial will consist of a short 10 min
warm-up cycle at the power output equivalent to 95% GET followed by a partial time trial of
fixed work at self-selected cycling speed and a full time trial of fixed work at
self-selected cycling speed. The participant will also be shown a demonstration for the use
of a faecal collection sampling device that will be used prior to the following visit, the
device will be given to them to take away from the laboratory at used at home.
Visit 3
At least 72 hours hours following visit 2, the participant will be asked to attend the
laboratory during the morning of the trial after after a 10-hour overnight fast. Participants
will then complete visual analogue scales (VAS) to assess their appetite ratings. Appetite
ratings will be assessed using 100 m VAS. They will then be provided with a standardised
breakfast. The participant will also be asked to collect faecal samples at any convenient
point in the 48 hours prior to the visit. The participant will then complete a questionnaire
to assess their mood and anxiety profile as well as a food frequency questionnaire (FFQ).
Other routine anthropometric information will be collected including height, body mass, blood
pressure/pulse wave analysis, resting heart rate, body fat % and lean body mass, following a
resting period. The participant will complete an exercise protocol that consists of a 45 min
steady-state exercise at 95% GET intensity calculated from familiarisation trial. Following
completion of the steady-state exercise, the participant will be asked to complete a cycling
performance time trial in which they will be asked to complete a set amount of work as
quickly as they are able. The work target is estimated using data obtained during
familiarisation time trial. The set workload will be adjusted for female participants. Blood
sampling will be collected prior to and following the steady-state exercise, and following
completion of the time trial. Participants will then be randomised into a study group
(probiotic or placebo). The participant will be asked to take the first dose prior to leaving
the laboratory, with further doses of one capsule per day with breakfast.
Visit 4
During week 7 of supplementation, the participant will return to the laboratory to repeat the
time trial completed as part of experimental trial 1 as a re-familiarisation exercise.
Participants will then be familiarised with performing a counter movement jumps (CMJ).
Thereafter, they will be familiarised with a hand-held pressure pain threshold (PPT)
algometer.
Visit 5
Following 8 weeks from visit 3, the participants will return to the laboratory at after a
10-hour overnight fast. They will provide faecal samples (collected within 48 hours prior to
the visit) and complete appetite, mood and anxiety questionnaires alongside a repeat FFQ.
They will then repeat the same exercise performance testing protocol as done in Visit 3.
Following the cessation of the performance trial 2, the participant will rest for at least 15
minutes or until their heart rate has returned to within 30 bpm of their pre-exercise level.
They will then complete 100 drop jumps. Blood sampling will be collected prior to and
following the steady-state exercise, following completion of the time trial, and at 1-hour
after the completion of the drop jumps.
Visits 6, 7 and 8
The participant will be asked to return to the laboratory at 24, 48 and 72 hours post-Visit 5
after a 10-hour overnight fast and a resting blood sample will be collected. Subsequently,
participants will perform 3 CMJs, 30 s apart with passive recovery. Then they will be asked
to perform a squat and then rate their current delayed onset muscle soreness (DOMS) using a
200 mm (VAS) for generalised muscle pain. A hand-held PPT algometer will be used for the
assessment of muscle-specific soreness at specific sites across the major muscles groups of
the lower limbs. All sites will be marked to ensure that pressure is applied at the same spot
for each repetition.